Sign in

CIK 0000907654

  • Non-accelerated filer
  • Smaller reporting company

Oruka Therapeutics, Inc.

Sign in to watch
Ticker
ORKA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
363855489
Phone
+1 650-606-7910
Business address
855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
Former names
ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Grant or award Chief Operating Officer acquired 40,000 shares (grant or award)
  8. 4 Grant or award Chief Financial Officer acquired 40,000 shares (grant or award)
  9. 4 Other disposition 10% owner disposed of 2,580,452 shares (other)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 4 Open-market buy See Footnote 1 bought 85,262 shares at an average $2.32 ($197,404)
  14. 4 Open-market buy See Footnote 1 bought 13,073 shares at an average $2.30 ($30,128)
  15. 4 Open-market buy See Footnote 1 bought 84,836 shares at an average $2.29 ($194,143)
  16. 4 Open-market buy See Footnote 1 bought 45,575 shares at an average $2.28 ($104,128)
  17. 4 Open-market buy See Footnote 1 bought 124,122 shares at an average $2.28 ($282,563)
  18. 4 Open-market buy See Footnote 1 bought 33,614 shares at an average $2.31 ($77,730)
  19. 4 Open-market buy See Footnote 1 bought 13,751 shares at $2.29 ($31,508)
  20. 4 Open-market buy See Footnote 1 bought 9,119 shares at $2.31 ($21,080)

Page 6 of 23 · 459 filings